GDF15 and metabolic dysfunction-associated steatotic liver disease: The novel findings in this study are that in patients with NAFLD, HbA1c concentrations explain a large proportion (~30%) of the variance in GDF-15 concentrations and that circulating concentration of GDF-15 may be involved in the known association between T2DM and liver fibrosis.